North America Generic Injectables Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others)

No. of Pages: 161    |    Report Code: BMIRE00025004    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Generic Injectables Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Generic Injectables Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Generic Injectables Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in generic drug production and sales
  • 5.1.2 Rising demand for generic injectables in the pharmaceutical industry
5.2 Market Opportunities
  • 5.2.1 Growth in generic drug demand globally
  • 5.2.2 Expanding opportunities for generic injectables in emerging pharmaceutical markets
5.3 Future Trends
  • 5.3.1 Growth in the demand for cost-effective medications
  • 5.3.2 availability of biosimilar and generic injectables
  • 5.3.3 Rising demand in chronic disease treatments.
5.4 Impact of Drivers and Restraints

6. North America Generic Injectables Market Regional Analysis

6.1 North America Generic Injectables Market Overview
6.2 North America Generic Injectables Market Revenue 2019-2028 (US$ Million)
6.3 North America Generic Injectables Market Forecast Analysis

7. North America Generic Injectables Market Analysis – by Product Type

7.1 Large Molecule Injectables
  • 7.1.1 Overview
  • 7.1.2 Large Molecule Injectables: North America Generic Injectables Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Small Molecule Injectables
  • 7.2.1 Overview
  • 7.2.2 Small Molecule Injectables: North America Generic Injectables Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Generic Injectables Market Analysis – by Container Type

8.1 Vials
  • 8.1.1 Overview
  • 8.1.2 Vials: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Premix
  • 8.2.1 Overview
  • 8.2.2 Premix: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Prefilled Syringes
  • 8.3.1 Overview
  • 8.3.2 Prefilled Syringes: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Ampoules
  • 8.4.1 Overview
  • 8.4.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

9. North America Generic Injectables Market Analysis – by Application

9.1 Oncology
  • 9.1.1 Overview
  • 9.1.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Infectious Diseases
  • 9.2.1 Overview
  • 9.2.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Cardiology
  • 9.3.1 Overview
  • 9.3.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Diabetes
  • 9.4.1 Overview
  • 9.4.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Immunology
  • 9.5.1 Overview
  • 9.5.2 Ampoules: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)

10. North America Generic Injectables Market – North America Analysis

10.1 North America
  • 10.1.1 North America Generic Injectables Market Breakdown, by Key Country, 2022 and 2028 (%)
  • 10.1.1.1 North America Generic Injectables Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.1.1 US: North America Generic Injectables Market Breakdown, by Product Type
    • 10.1.1.1.2 US: North America Generic Injectables Market Breakdown, by Container Type
    • 10.1.1.1.3 US: North America Generic Injectables Market Breakdown, by Application
  • 10.1.1.2 Canada: North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.2.1 Canada: North America Generic Injectables Market Breakdown, by Product Type
    • 10.1.1.2.2 Canada: North America Generic Injectables Market Breakdown, by Container Type
    • 10.1.1.2.3 Canada: North America Generic Injectables Market Breakdown, by Application
  • 10.1.1.3 Mexico : North America Generic Injectables Market – Revenue and Forecast to 2028 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Generic Injectables Market Breakdown, by Product Type
    • 10.1.1.3.2 Mexico : North America Generic Injectables Market Breakdown, by Container Type
    • 10.1.1.3.3 Mexico : North America Generic Injectables Market Breakdown, by Application

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Generic Injectables Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 AstraZeneca
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Baxter International Inc.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Biocon
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Fresenius SE & Co. KGaA
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 GlaxoSmithKline plc
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Hikma Pharmaceuticals PLC
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Johnson and Johnson Services, Inc.
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Lupin
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Merck & Co., Inc.
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Pfizer Inc.
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments
13.11 Viatris Inc
  • 13.11.1 Key Facts
  • 13.11.2 Business Description
  • 13.11.3 Products and Services
  • 13.11.4 Financial Overview
  • 13.11.5 SWOT Analysis
  • 13.11.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Generic Injectables Market

  1. AstraZeneca
  2. Baxter International Inc.
  3. Biocon
  4. Fresenius SE & Co. KGaA
  5. GlaxoSmithKline plc
  6. Hikma Pharmaceuticals PLC
  7. Johnson and Johnson Services, Inc.
  8. Lupin
  9. Merck & Co., Inc.
  10. Pfizer Inc.
  11. Viatris Inc
north-america-generic-injectables-market